Skip to main content
Clinical Trials/RBR-4hpxhxh
RBR-4hpxhxh
Recruiting
Phase 4

Preoperative use of Pregabalin versus Placebo: a randomized, double-blind, controlled trial to assess the Quality of anesthetic recovery in patients undergoing Breast cancer surgery

Faculdade de Medicina de Jundiaí0 sitesMarch 14, 2023

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Faculdade de Medicina de Jundiaí
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 14, 2023
End Date
January 1, 2024
Last Updated
2 years ago
Study Type
Intervention
Sex
Female

Investigators

Sponsor
Faculdade de Medicina de Jundiaí

Eligibility Criteria

Inclusion Criteria

  • They will integrate 80 patients aged between 20 and 65 years and physical status ASA I or II, who will undergo elective breast cancer surgeries, performed at the University Hospital of the Faculty of Medicine of Jundiaí (Jundiaí\-SP).

Exclusion Criteria

  • Patient refusal; altered level of consciousness or inability to communicate; presence of any contraindication to the use of any agent described in the project; history of seizure disorder; currently using pregabalin or gabapentin; presence of chronic pain or use of opioids; body mass index (BMI) \>40 kg/m2; insulin\-dependent diabetes mellitus and renal failure (estimated glomerular filtration rate less than 60 ml/min/1\.73 m²); violation of the protocol (such as the use of agents not described in the study protocol); refusal to respond to the questionnaire (QoR\-15\) in the perioperative period.

Outcomes

Primary Outcomes

Not specified

Similar Trials